- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 403/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring- member bond
Patent holdings for IPC class C07D 403/04
Total number of patents in this class: 7168
10-year publication summary
|
507
|
565
|
549
|
537
|
580
|
596
|
541
|
485
|
513
|
122
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5909 |
152 |
| Bristol-myers Squibb Company | 5080 |
127 |
| Novartis AG | 11238 |
118 |
| Janssen Pharmaceutica N.V. | 3839 |
95 |
| Boehringer Ingelheim International GmbH | 4629 |
94 |
| AstraZeneca AB | 3042 |
88 |
| F. Hoffmann-La Roche AG | 7958 |
84 |
| Bayer AG | 3045 |
76 |
| Takeda Pharmaceutical Company Limited | 2961 |
74 |
| Rohm and Haas Electronic Materials Korea Ltd. | 546 |
70 |
| Merck Sharp & Dohme LLC | 3689 |
69 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
61 |
| Syngenta Participations AG | 4970 |
60 |
| Syngenta Crop Protection AG | 2790 |
60 |
| Vertex Pharmaceuticals Incorporated | 1581 |
60 |
| Hoffmann-La Roche Inc. | 3060 |
59 |
| LG Chem, Ltd. | 17205 |
58 |
| Genentech, Inc. | 3742 |
55 |
| Bayer Pharma AG | 1096 |
50 |
| Araxes Pharma LLC | 91 |
49 |
| Other owners | 5609 |